Hartley Taylor

King’s College Hospital CAR-T Cell Preceptorship Course

2- 3 November 2020
Virtual Event

Course Leads

Dr Vishal Jayakar, MD, MRCP, FRCPath

Dr Vishal Jayakar, MD, MRCP, FRCPath

Consultant Haemato-Oncologist, Kingston Hospital NHS Foundation Trust
Lead for Commercial Education & Training, King’s Haematology Partners
Honorary Senior Lecturer, Imperial College London

Full profile...

Completing his haematology training from Imperial College NHS Trusts, Dr Jayakar has been a Consultant Haemato-Oncologist at Kingston Hospital, London since 2010. He runs the popular FRCPath 1 and 2 exam oriented courses which are subscribed by haematology trainees from all over the UK including delegates from UAE, Singapore, Hong-Kong, India and Sri-Lanka. He also co-organises the venerable Imperial Morphology Courses with Professor Barbara Bain. He has been appointed at King’s College London as faculty in an academic role for education and training and steers the preceptorship programme.

Dr Victoria Potter

Dr Victoria Potter

Consultant Haematologist, King’s College Hospital

Full profile...

Dr Victoria Potter is a Consultant Haematologist specialising in stem cell transplantation at King’s College Hospital, London. After graduating from the University of Sydney she completed early post-graduate and specialty training in haematology in Sydney, Australia, working at Westmead, Prince of Wales and St Vincent’s Hospitals. In 2010 she moved to London to take up a clinical fellowship position at King’s before accepting a consultant position in myeloid malignancies and transplantation. During this time she participated in the visiting physicians programme at Fred Hutchinson Cancer Centre Seattle. In November 2017, Victoria was appointed BMT Director at King’s College Hospital. She is a member of the CMWP of the EBMT and is committed to the development of clinical trials in transplantation. She is the IMPACT principal investigator for King’s College Hospital London and the current secretary of the BSBMT clinical trials committee.

Her research interests focus on the use of DLI for the prevention of relapse post-transplant. Dr Potter is fully trained in the assessment of patients for, and delivery of, CAR-T therapy and is active in the development of an early trial for the delivery of allogeneic CAR-T therapy in acute myeloid leukaemia.

Dr Reuben Benjamin

Dr Reuben Benjamin

Consultant Haematologist, King’s College Hospital

Full profile...

Reuben Benjamin is a haematologist with an interest in multiple myeloma, stem cell transplantation and cell therapy. He completed his haematology training at University College Hospital, London and then spent a period at Memorial Sloan Kettering Cancer Center, NY undertaking research in CAR-T cell therapy for leukaemia and myeloma. Since 2014 he has been based at King’s College Hospital, London where he leads the plasma cell disorder service and CAR-T cell programme. He is currently leading the first allogeneic off-the-shelf CAR-T cell study for relapsed adult B-ALL (CALM Trial).

© Hartley Taylor - Website design and maintenance: Byte Sized Solutions